MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Impulse Control Disorders in a Brazilian population with Parkinson´s disease -an observational study

    B. Veiga, V. Borges, H. Ferraz, C. Aquino, C. Giacominelli, SM. Silva, S. Lestingi (São Paulo, Brazil)

    Objective: To Analyse Impulse Control Disorders (ICDs) and Related Behaviors (RB) in 36 Brazilian patients with Parkinson´s disease (PD) and compare the cognition of the…
  • 2019 International Congress

    Social cognition in Parkinson’s disease

    L. Alonso-Recio, C. Merino, P. Martín, JM. Serrrano (Collado Villalba (madrid), Spain)

    Objective: The aim of the present study was to assess social cognition skills in non-demented Parkinson’s disease (PD) patients. Background: Social cognition is a multidimensional…
  • 2019 International Congress

    Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

    G. Chandran (Mysore, India)

    Objective: To assess the non-inducing doses of scopolamine (SCL) on the memory function of Drosophila previously induced with Parkinson's disease phenotype. Background: A large body…
  • 2019 International Congress

    Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

    JJ. Hu, T. Wang (Wuhan, China)

    Objective: To investigate the role and mechanism of C3a receptor in okadaic acid(OA) induced SH-SY5Y cells tau hyperphosphorylation model Background: Neurofibrillary tangles aggregated from hyperphosphorylated…
  • 2019 International Congress

    Tau pathology is associated to cognitive and not motor function in Parkinson’s disease

    I. Liepelt-Scarfone, H. Vanderstichele, W. Maetzler, C. Francois, C. Schulte, M. Timmers, L. van Nueten, G. Salvadore, K. Brockmann, T. Gasser, J. Streffer, E. Stoops, D. Berg (Tübingen, Germany)

    Objective: To define the association of different cerebrospinal fluid (CSF) biomarkers reflecting Aß and Tau pathology or synaptic function with motor and/or cognitive function in…
  • 2019 International Congress

    Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

    A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

    Objective: To analyze the cognitive profile of patients with degenerative parkinsonian syndromes in the French West Indies and explore the correlations between cognitive deficits and…
  • 2019 International Congress

    Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

    V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)

    Objective: The study aimed to examine the neurocognitive changes following STN-DBS in patients with PD. Background: Neurocognitive evaluation is a standard procedure preoperatively in patients…
  • 2019 International Congress

    Movement and symptom-modulated local field potentials in globus pallidus internus of Parkinson’s disease

    J. Aman, L. Johnson, D. Sanabria, J. Wang, M. Hill, S. Cooper, L. Schrock, M. Petrucci, G. Molnar, C. Mackinnon, R. Patriat, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)

    Objective: To examine the relationship between local field potential (LFP) activity recorded from directional deep brain stimulation (DBS) leads in the internal segment of the…
  • 2019 International Congress

    The Circulatory Levels of Serotonin, Beta endorphin and Dopamine and their relations to Pain Perception in People with Parkinson’s Disease

    H. Khalil, N. Al-Yahya, A. Al-Sharman, M. Alqudah, K. El-Salem (Irbid, Jordan)

    Objective: 1) to examine circulatory serotonin, beta-endorphin and the dopamine metabolite homovanillic acid (HVA) in people with PD, 2) to explore the relationship of the…
  • 2019 International Congress

    Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

    R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)

    Objective: To investigate the change of striatal serotonergic system according to the administration of levodopa and zonisamide (ZNS) on the striatal serotonergic system, we analyzed the…
  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley